Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
about
Hepatitis B virus and its sexually transmitted infection - an update.Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.Investigation into the effect of hepatitis B virus on apoliprotein A1 expression and its mechanismUnveiling the roles of HBV polymerase for new antiviral strategiesAntiviral drug resistance increases hepatocellular carcinoma: a prospective decompensated cirrhosis cohort studyPrevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection.The Anticancer Properties and Apoptosis-inducing Mechanisms of Cinnamaldehyde and the Herbal Prescription Huang-Lian-Jie-Du-Tang ( Huáng Lián Jiě Dú Tang) in Human Hepatoma Cells.Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells.The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma.FoxO3a nuclear localization and its association with β-catenin and Smads in IFN-α-treated hepatocellular carcinoma cell lines.Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis.Adjuvant interferon therapy after surgical treatment for hepatitis B/C virus-related hepatocellular carcinoma: A meta-analysis.Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B.Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort study.
P2860
Q30235028-881CD5B1-6392-48AC-8351-3675A2EE1711Q34028475-B9EC094A-DD3F-4925-8B33-765E959AD71AQ34135965-7F0A3C56-3BAA-4874-B799-40EEA4ACC3E3Q35441503-2BAD35A6-CFAF-492E-95F1-A0D791C03A83Q37378970-2F585B79-5B36-49D2-954E-664199B2F819Q37408920-E733E552-11CA-49A8-A12A-4CAC0B523B68Q37585346-BCFBB2DC-B2C5-4E04-A1FD-0869D63EE323Q37598554-4F7218A5-3B0C-4B4B-9D37-DA8202C98F74Q38246712-45CE0460-6A7D-41CF-B31A-91647E547F05Q38784573-2818E6EA-A9DB-45D7-9340-7613C8989302Q42092099-4D7F10C6-C82A-4EFD-B241-D3C889DAECC2Q42173015-2ED3F3DE-D6AD-49C2-90C2-8457F99EFCA3Q45351713-BB35DBAB-91FC-416D-A428-AF3D2BB49769Q48136392-AFEE3576-0469-46B3-A6F1-72EA90DDE545Q49802355-E041E78D-341A-4B81-B77E-8DE5C158850F
P2860
Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prevention of hepatocellular c ...... c hepatitis B virus infection.
@en
Prevention of hepatocellular c ...... c hepatitis B virus infection.
@nl
type
label
Prevention of hepatocellular c ...... c hepatitis B virus infection.
@en
Prevention of hepatocellular c ...... c hepatitis B virus infection.
@nl
prefLabel
Prevention of hepatocellular c ...... c hepatitis B virus infection.
@en
Prevention of hepatocellular c ...... c hepatitis B virus infection.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prevention of hepatocellular c ...... ic hepatitis B virus infection
@en
P2093
Beom Kyung Kim
Kwang-Hyub Han
Sang Hoon Ahn
P2860
P356
10.1159/000333258
P478
81 Suppl 1
P577
2011-12-22T00:00:00Z